{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:35:07Z","timestamp":1790699707516,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10787-026-02153-1","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:33:38Z","timestamp":1771572818000},"page":"2003-2025","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Azilsartan prevents central modulation of BDNF and PPAR\u03b3 in Alzheimer\u2019s pathology through amyloidogenic and inflammatory pathways: experimental and computational evidence"],"prefix":"10.1007","volume":"34","author":[{"given":"Varnita","family":"Karmakar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pran Kishore","family":"Deb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bapi","family":"Gorain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"2153_CR1","doi-asserted-by":"publisher","first-page":"118020","DOI":"10.1016\/j.lfs.2020.118020","volume":"257","author":"M Amidfar","year":"2020","unstructured":"Amidfar M, de Oliveira J, Kucharska E et al (2020) The role of CREB and BDNF in neurobiology and treatment of Alzheimer\u2019s disease. Life Sci 257:118020. https:\/\/doi.org\/10.1016\/j.lfs.2020.118020","journal-title":"Life Sci"},{"key":"2153_CR2","doi-asserted-by":"publisher","first-page":"101812","DOI":"10.1016\/j.toxrep.2024.101812","volume":"13","author":"GE Anyanwu","year":"2024","unstructured":"Anyanwu GE, Nwachukwu IJ, Oria SR et al (2024) Fisetin attenuates AlCl3-induced neurodegeneration by modulating oxidative stress and inflammatory cytokine release in adult albino wistar rats. Toxicol Rep 13:101812. https:\/\/doi.org\/10.1016\/j.toxrep.2024.101812","journal-title":"Toxicol Rep"},{"issue":"4","key":"2153_CR3","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1007\/S12011-024-04292-4","volume":"203","author":"FM Attia","year":"2024","unstructured":"Attia FM, Kassab RB, Ahmed-Farid OA et al (2024) Zinc oxide nanoparticles attenuated neurochemical and histopathological alterations associated with aluminium chloride intoxication in rats. Biol Trace Elem Res 203(4):2058\u20132071. https:\/\/doi.org\/10.1007\/S12011-024-04292-4","journal-title":"Biol Trace Elem Res"},{"key":"2153_CR4","doi-asserted-by":"publisher","first-page":"138336","DOI":"10.1016\/j.ijbiomac.2024.138336","volume":"286","author":"S Chakraborty","year":"2025","unstructured":"Chakraborty S, Karmakar V, Chatterjee K et al (2025) Chitosan nanoparticle-mediated nose-to-brain delivery of naringenin: attenuating memory decline in experimental animals via behavioural assessment and modulation of biochemical parameters. Int J Biol Macromol 286:138336. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138336","journal-title":"Int J Biol Macromol"},{"key":"2153_CR6","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1007\/s10787-023-01290-1","volume":"31","author":"K Chatterjee","year":"2023","unstructured":"Chatterjee K, Mitra P, Sugato M (2023) Vitamin K2 protects against aluminium chloride - mediated neurodegeneration. Inflammopharmacology 31:2675\u20132684. https:\/\/doi.org\/10.1007\/s10787-023-01290-1","journal-title":"Inflammopharmacology"},{"key":"2153_CR5","doi-asserted-by":"publisher","first-page":"177277","DOI":"10.1016\/j.ejphar.2025.177277","volume":"990","author":"K Chatterjee","year":"2025","unstructured":"Chatterjee K, Mazumder PM, Banerjee S (2025) Vitamin K2 protects against D-galactose induced ageing in mice. Eur J Pharmacol 990:177277. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177277","journal-title":"Eur J Pharmacol"},{"key":"2153_CR70","doi-asserted-by":"crossref","unstructured":"Chowdhury S (2023) Monoclonal antibody treatments for Alzheimer's disease: aducanumab and lecanemab. Discoveries 11(3):e173","DOI":"10.15190\/d.2023.12"},{"key":"2153_CR7","doi-asserted-by":"publisher","first-page":"586314","DOI":"10.3389\/FNINS.2020.586314","volume":"14","author":"C Cosarderelioglu","year":"2020","unstructured":"Cosarderelioglu C, Nidadavolu LS, George CJ et al (2020) Brain renin\u2013angiotensin system at the intersect of physical and cognitive frailty. Front Neurosci 14:586314. https:\/\/doi.org\/10.3389\/FNINS.2020.586314","journal-title":"Front Neurosci"},{"key":"2153_CR8","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","volume":"59","author":"M De Vivo","year":"2016","unstructured":"De Vivo M, Masetti M, Bottegoni G, Cavalli A (2016) Role of molecular dynamics and related methods in drug discovery. J Med Chem 59:4035\u20134061. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01684","journal-title":"J Med Chem"},{"key":"2153_CR9","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1161\/HYPERTENSIONAHA.122.19378","volume":"79","author":"Z Deng","year":"2022","unstructured":"Deng Z, Jiang J, Wang J et al (2022) Angiotensin receptor blockers are associated with a lower risk of progression from mild cognitive impairment to dementia. Hypertension 79:2159\u20132169. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.122.19378","journal-title":"Hypertension"},{"key":"2153_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-1-62703-791-4_9","volume":"1120","author":"R D\u2019Isa","year":"2014","unstructured":"D\u2019Isa R, Brambilla R, Fasano S (2014) Behavioral methods for the study of the Ras-ERK pathway in memory formation and consolidation: passive avoidance and novel object recognition tests. Methods Mol Biol 1120:131\u2013156. https:\/\/doi.org\/10.1007\/978-1-62703-791-4_9","journal-title":"Methods Mol Biol"},{"key":"2153_CR11","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41591-024-03340-9","volume":"31","author":"M Fang","year":"2025","unstructured":"Fang M, Hu J, Weiss J et al (2025) Lifetime risk and projected burden of dementia. Nat Med 31:772\u2013776. https:\/\/doi.org\/10.1038\/s41591-024-03340-9","journal-title":"Nat Med"},{"key":"2153_CR12","doi-asserted-by":"publisher","first-page":"114097","DOI":"10.1016\/j.biopha.2022.114097","volume":"158","author":"MA Fawzy","year":"2023","unstructured":"Fawzy MA, Beshay ON, Bekhit AA et al (2023) Nephroprotective effect of AT-MSCs against cisplatin-induced EMT is improved by azilsartan via attenuating oxidative stress and TGF-\u03b2\/Smad signaling. Biomed Pharmacother 158:114097. https:\/\/doi.org\/10.1016\/j.biopha.2022.114097","journal-title":"Biomed Pharmacother"},{"key":"2153_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00279-0","author":"L Gao","year":"2022","unstructured":"Gao L, Zhang Y, Sterling K, Song W (2022) Brain-derived neurotrophic factor in Alzheimer\u2019s disease and its pharmaceutical potential. Transl Neurodegener. 11:4.\u00a0https:\/\/doi.org\/10.1186\/s40035-022-00279-0","journal-title":"Transl Neurodegener"},{"key":"2153_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-38","author":"P Garrido-Gil","year":"2012","unstructured":"Garrido-Gil P, Joglar B, Rodriguez-Perez AI et al (2012) Involvement of PPAR-\u03b3 in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson\u2019s disease. J Neuroinflammation. 9:38.\u00a0https:\/\/doi.org\/10.1186\/1742-2094-9-38","journal-title":"J Neuroinflammation"},{"key":"2153_CR15","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/jamaneurol.2015.1001.Research","volume":"72","author":"I Hajjar","year":"2015","unstructured":"Hajjar I, Allan L (2015) Research Letter: Use of angiotensin receptor blockers is associated with longitudinal decline in Tau in mild cognitive impairment in ADNI. JAMA Neurol 72:1069\u20131070. https:\/\/doi.org\/10.1001\/jamaneurol.2015.1001.Research","journal-title":"JAMA Neurol"},{"key":"2153_CR16","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K et al (2021) The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry 26:5481\u20135503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0","journal-title":"Mol Psychiatry"},{"key":"2153_CR17","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.ibneur.2025.05.005","volume":"18","author":"P Kamila","year":"2025","unstructured":"Kamila P, Kar K, Chowdhury S et al (2025) Effect of neuroinflammation on the progression of Alzheimer\u2019s disease and its significant ramifications for novel anti-inflammatory treatments. IBRO Neurosci Rep 18:771\u2013782. https:\/\/doi.org\/10.1016\/j.ibneur.2025.05.005","journal-title":"IBRO Neurosci Rep"},{"key":"2153_CR18","doi-asserted-by":"publisher","first-page":"103850","DOI":"10.1016\/J.DRUDIS.2023.103850","volume":"29","author":"V Karmakar","year":"2024","unstructured":"Karmakar V, Gorain B (2024) Potential molecular pathways of angiotensin receptor blockers in the brain toward cognitive improvement in dementia. Drug Discov Today 29:103850. https:\/\/doi.org\/10.1016\/J.DRUDIS.2023.103850","journal-title":"Drug Discov Today"},{"key":"2153_CR19","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1039\/d5bm00066a","volume":"13","author":"V Karmakar","year":"2025","unstructured":"Karmakar V, Lim WM, Gorain B (2025a) Mechanistic insights into a thermoresponsive in situ nanoemulgel of azilsartan medoxomil for intranasal delivery: a promising nanotherapeutic approach to target dementia. Biomater Sci 13:3853\u20133875. https:\/\/doi.org\/10.1039\/d5bm00066a","journal-title":"Biomater Sci"},{"key":"2153_CR20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1021\/ACSCHEMNEURO.5C00769","volume":"17","author":"V Karmakar","year":"2025","unstructured":"Karmakar V, Majie A, Ghosh A et al (2025b) Decoding the neuroprotective intervention of angiotensin receptor blockers: a multimodal approach using in silico network pharmacology, molecular modeling, and in vivo validation of key markers. ACS Chem Neurosci 17:214\u2013230. https:\/\/doi.org\/10.1021\/ACSCHEMNEURO.5C00769","journal-title":"ACS Chem Neurosci"},{"key":"2153_CR21","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/276393","author":"M Kawahara","year":"2011","unstructured":"Kawahara M, Kato-Negishi M (2011) Link between aluminum and the pathogenesis of Alzheimer\u2019s disease: the integration of the aluminum and amyloid cascade hypotheses. Int J Alzheimers Dis.\u00a0276393.\u00a0https:\/\/doi.org\/10.4061\/2011\/276393","journal-title":"Int J Alzheimers Dis"},{"key":"2153_CR22","doi-asserted-by":"publisher","first-page":"000","DOI":"10.14218\/jerp.2023.00028","volume":"000","author":"K Khan","year":"2024","unstructured":"Khan K, Emad NA, Sultana Y (2024) Inducing agents for Alzheimer\u2019s disease in animal models. J Explor Res Pharmacol 9:169\u2013179. https:\/\/doi.org\/10.14218\/jerp.2023.00028","journal-title":"J Explor Res Pharmacol"},{"issue":"1","key":"2153_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/S12011-015-0229-3","volume":"165","author":"BVS Lakshmi","year":"2015","unstructured":"Lakshmi BVS, Sudhakar M, Prakash KS (2015) Protective effect of selenium against aluminum chloride-induced Alzheimer\u2019s disease: behavioral and biochemical alterations in rats. Biol Trace Elem Res 165(1):67\u201374. https:\/\/doi.org\/10.1007\/S12011-015-0229-3","journal-title":"Biol Trace Elem Res"},{"key":"2153_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/BMJ.B5465","volume":"340","author":"NC Li","year":"2010","unstructured":"Li NC, Lee A, Whitmer RA et al (2010) Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ 340:141. https:\/\/doi.org\/10.1136\/BMJ.B5465","journal-title":"BMJ"},{"key":"2153_CR25","doi-asserted-by":"publisher","first-page":"214474","DOI":"10.1016\/j.bioadv.2025.214474","volume":"178","author":"A Majie","year":"2026","unstructured":"Majie A, Karmakar V, Ghosh A et al (2026) Advanced intranasal peptide delivery systems for improved management of Alzheimer\u2019s disease. Biomater Adv 178:214474. https:\/\/doi.org\/10.1016\/j.bioadv.2025.214474","journal-title":"Biomater Adv"},{"key":"2153_CR26","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.ijbiomac.2018.06.190","volume":"118","author":"S Md","year":"2018","unstructured":"Md S, Gan SY, Haw YH et al (2018) In vitro neuroprotective effects of naringenin nanoemulsion against \u03b2-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation. Int J Biol Macromol 118:1211\u20131219. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.06.190","journal-title":"Int J Biol Macromol"},{"key":"2153_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-022-02322-3","author":"M Nafea","year":"2023","unstructured":"Nafea M, Elharoun M, Mohmoud M et al (2023) Leflunomide abrogates neuroinflammatory changes in a rat model of Alzheimer\u2019s disease: the role of TNF - \u03b1\/NF - \u03baB\/IL - 1\u03b2 axis inhibition. Naunyn Schmiedebergs Arch Pharmacol. 396:485\u2013498.\u00a0https:\/\/doi.org\/10.1007\/s00210-022-02322-3","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2153_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112296","author":"D Nunes","year":"2022","unstructured":"Nunes D, Loureiro JA, Pereira MC (2022) Drug delivery systems as a strategy to improve the efficacy of FDA-approved Alzheimer\u2019s drugs. Pharmaceutics. 14:2296.\u00a0https:\/\/doi.org\/10.3390\/pharmaceutics14112296","journal-title":"Pharmaceutics"},{"key":"2153_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00605-8","author":"FG Ortiz","year":"2023","unstructured":"Ortiz FG, Kac PR, Brum WS et al (2023) Plasma phosphor-tau in Alzheimer\u2019s disease: towards diagnostic and therapeutic trial applications. Mol Neurodegener. 18:18.\u00a0https:\/\/doi.org\/10.1186\/s13024-023-00605-8","journal-title":"Mol Neurodegener"},{"key":"2153_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112841","author":"P Rawat","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J et al (2022) Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci. 23:12841.\u00a0https:\/\/doi.org\/10.3390\/ijms232112841","journal-title":"Int J Mol Sci"},{"key":"2153_CR31","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1016\/j.neurobiolaging.2013.03.015","volume":"34","author":"T Rodr\u00edguez-Mart\u00edn","year":"2013","unstructured":"Rodr\u00edguez-Mart\u00edn T, Cuchillo-Ib\u00e1\u00f1ez I, Noble W et al (2013) Tau phosphorylation affects its axonal transport and degradation. Neurobiol Aging 34:2146\u20132157. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.03.015","journal-title":"Neurobiol Aging"},{"key":"2153_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.PSYNEUEN.2010.10.001","volume":"36","author":"JM Saavedra","year":"2010","unstructured":"Saavedra JM, S\u00e1nchez-Lemus E, Benicky J (2010) Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: therapeutic implications. Psychoneuroendocrinology 36:1\u201318. https:\/\/doi.org\/10.1016\/J.PSYNEUEN.2010.10.001","journal-title":"Psychoneuroendocrinology"},{"key":"2153_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-66424-z","volume":"14","author":"S Sadeghian","year":"2024","unstructured":"Sadeghian S, Razmi R, Khabnadideh S et al (2024) Synthesis, biological evaluation, molecular docking, and MD simulation of novel 2,4-disubstituted quinazoline derivatives as selective butyrylcholinesterase inhibitors and antioxidant agents. Sci Rep 14:1\u201314. https:\/\/doi.org\/10.1038\/s41598-024-66424-z","journal-title":"Sci Rep"},{"key":"2153_CR34","doi-asserted-by":"publisher","first-page":"2054-2057","DOI":"10.1161\/01.CIR.0000127955.36250.65","volume":"109","author":"M Schupp","year":"2004","unstructured":"Schupp M, Janke J, Clasen R, Unger T, Kintscher U (2004) Angiotensin type 1 receptor blockers induce peroxisome proliferator\u2013activated receptor-activity. Circulation. 109:2054-2057. https:\/\/doi.org\/10.1161\/01.CIR.0000127955.36250.65","journal-title":"Circulation"},{"key":"2153_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-65166-2","volume":"14","author":"WS Shehab","year":"2024","unstructured":"Shehab WS, Haikal HA, Elsayed DA et al (2024) Pharmacokinetic and molecular docking studies to pyrimidine drug using Mn3O4 nanoparticles to explore potential anti-Alzheimer activity. Sci Rep 14:1\u201314. https:\/\/doi.org\/10.1038\/s41598-024-65166-2","journal-title":"Sci Rep"},{"key":"2153_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/f1000research.145391.3","volume":"13","author":"SR Shri","year":"2025","unstructured":"Shri SR, Nayak Y, Ranganath Pai S (2025) Molecular docking studies and molecular dynamic simulation analysis: to identify novel ATP-competitive inhibition of Glycogen synthase kinase-3\u03b2 for Alzheimer\u2019s disease. F1000Res 13:1\u201329. https:\/\/doi.org\/10.12688\/f1000research.145391.3","journal-title":"F1000Res"},{"key":"2153_CR37","doi-asserted-by":"publisher","first-page":"111369","DOI":"10.1016\/j.biopha.2021.111369","volume":"137","author":"D Shunan","year":"2021","unstructured":"Shunan D, Yu M, Guan H, Zhou Y (2021) Neuroprotective effect of betalain against AlCl3-induced Alzheimer\u2019s disease in Sprague Dawley rats via putative modulation of oxidative stress and nuclear factor kappa B (NF-\u03baB) signaling pathway. Biomed Pharmacother 137:111369. https:\/\/doi.org\/10.1016\/j.biopha.2021.111369","journal-title":"Biomed Pharmacother"},{"key":"2153_CR38","doi-asserted-by":"publisher","first-page":"610","DOI":"10.5530\/ijper.57.3s.69","volume":"57","author":"MK Siddalingappa","year":"2023","unstructured":"Siddalingappa MK, Vittalrao AM, Kamalkishore MK, Mamulpet V (2023) Evaluation of cognition enhancing activities of telmisartan, nimodipine and their combination in REM sleep deprived Wistar Rats. Indian J Pharm Educ Res 57:610\u2013619. https:\/\/doi.org\/10.5530\/ijper.57.3s.69","journal-title":"Indian J Pharm Educ Res"},{"key":"2153_CR39","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1093\/BRAIN\/AWV172","volume":"138","author":"S Villapol","year":"2015","unstructured":"Villapol S, Balarezo MG, Affram K et al (2015) Neurorestoration after traumatic brain injury through angiotensin II receptor blockage. Brain 138:3299. https:\/\/doi.org\/10.1093\/BRAIN\/AWV172","journal-title":"Brain"},{"key":"2153_CR71","doi-asserted-by":"crossref","unstructured":"Vorhees CV, Williams MT (2006) Morris water maze: procedures for assessing spatial and related forms of learning andmemory. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1(2):848\u2013858.","DOI":"10.1038\/nprot.2006.116"},{"key":"2153_CR40","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nprot.2007.44","volume":"2","author":"AA Walf","year":"2007","unstructured":"Walf AA, Frye CA (2007) The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2:322\u2013328. https:\/\/doi.org\/10.1038\/nprot.2007.44","journal-title":"Nat Protoc"},{"key":"2153_CR41","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.pharep.2013.11.002","volume":"66","author":"D Wincewicz","year":"2014","unstructured":"Wincewicz D, Braszko JJ (2014) Telmisartan attenuates cognitive impairment caused by chronic stress in rats. Pharmacol Rep 66:436\u2013441. https:\/\/doi.org\/10.1016\/j.pharep.2013.11.002","journal-title":"Pharmacol Rep"},{"key":"2153_CR42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/S12012-022-09730-0","volume":"22","author":"H Wu","year":"2022","unstructured":"Wu H, Sun Q, Yuan S et al (2022) AT1 receptors: their actions from hypertension to cognitive impairment. Cardiovasc Toxicol 22:311\u2013325. https:\/\/doi.org\/10.1007\/S12012-022-09730-0","journal-title":"Cardiovasc Toxicol"},{"key":"2153_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22063278","volume":"22","author":"MH Yang","year":"2021","unstructured":"Yang MH, Chen YMA, Tu SC et al (2021) Utilizing an animal model to identify brain neurodegeneration-related biomarkers in aging. Int J Mol Sci 22:1\u201328. https:\/\/doi.org\/10.3390\/ijms22063278","journal-title":"Int J Mol Sci"},{"key":"2153_CR44","doi-asserted-by":"publisher","DOI":"10.1177\/1179573520907397","author":"KG Yiannopoulou","year":"2020","unstructured":"Yiannopoulou KG, Papageorgiou SG (2020) Current and future treatments in Alzheimer disease: an update. J Cent Nerv Syst Dis. 12.\u00a0https:\/\/doi.org\/10.1177\/1179573520907397","journal-title":"J Cent Nerv Syst Dis"},{"key":"2153_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1423-0127-19-51","volume":"19","author":"CY Yuan","year":"2012","unstructured":"Yuan CY, Lee YJ, Hsu GSW (2012) Aluminum overload increases oxidative stress in four functional brain areas of neonatal rats. J Biomed Sci 19:1\u20139. https:\/\/doi.org\/10.1186\/1423-0127-19-51","journal-title":"J Biomed Sci"},{"key":"2153_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01486-5","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 8:267.\u00a0https:\/\/doi.org\/10.1038\/s41392-023-01486-5","journal-title":"Signal Transduct Target Ther"},{"key":"2153_CR47","doi-asserted-by":"publisher","first-page":"104009","DOI":"10.1016\/j.jff.2020.104009","volume":"71","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Dang M, Zhang W et al (2020) Neuroprotective effects of syringic acid against aluminium chloride induced oxidative stress mediated neuroinflammation in rat model of Alzheimer\u2019s disease. J Funct Foods 71:104009. https:\/\/doi.org\/10.1016\/j.jff.2020.104009","journal-title":"J Funct Foods"},{"key":"2153_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-023-01266-0","volume":"26","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Orchard SG, Nelson MR et al (2024) Angiotensin receptor blockers and cognition: a scoping review. Curr Hypertens Rep 26:1\u201319. https:\/\/doi.org\/10.1007\/s11906-023-01266-0","journal-title":"Curr Hypertens Rep"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02153-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02153-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02153-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:03:48Z","timestamp":1773777828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02153-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2153"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02153-1","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}